Global Antibacterial Drugs Market

Transcription

1 Brochure More information from Global Antibacterial Drugs Market Description: About antibacterial drugs Antibacterial drugs are chemical compounds used to treat infections caused by bacteria either by killing or inhibiting the growth of bacteria. The term antibiotic is often used synonymously with an antibacterial. However, antibiotics are agents that work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. The term antibiotic was originally coined to refer to any compound of microbial origin, which is antagonistic to the growth of the microbe. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. They can be bacteriostatic or bactericidal in nature, i.e., they either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad-spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin). The report forecasts the global antibacterial drugs market to grow at a CAGR of 1.06% over the period Covered in this report In this report, the author the present scenario and growth prospects of the global antibacterial drugs market for To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria. The various classes of antibacterial drug included in this report are beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, folate antagonists, tetracyclines, and other miscellaneous agents, which include glycopeptides, nitroimidazoles, lincosamides, lipopeptides, nicotinic acid derivatives, and polypeptide antibiotics. The report, Global Antibacterial Drugs Market , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key regions - Americas - APAC - EMEA Key vendors - Allergan - GlaxoSmithKline - Merck - Novartis - Pfizer - Teva Pharmaceuticals Other prominent vendors - Abbott - Achaogen - Actelion - AmpliPhi Biosciences - Aspen Pharmacare - Astellas - AstraZeneca - Aurobindo Pharma - Baxter - Basilea Pharmaceuticals - Bayer - Biocon

2 - Bristol-Myers Squibb - Cempra - Cipher Pharmaceuticals - Corden Pharma - Cornerstone Therapeutics - Eli Lilly - Exoxemis - F. Hoffmann-La Roche - Flynn Pharma - Hospira - Incepta Pharmaceuticals - InSite Vision - Insmed Incorporated - Johnson & Johnson - KaloBios Pharmaceuticals - Kyorin Pharmaceutical - Lupin Pharmaceuticals - Lytix Biopharma - Melinta Therapeutics - Mylan - Nektar - Orchid Pharma - Par Pharmaceutical - Paratek Pharmaceuticals - Pernix Therapeutics - PTC Therapeutics - RedHill Biopharma - Sagent Pharmaceuticals - Sanofi - Shionogi - Starpharma - Sun Pharmaceutical - Symbiomix - Takeda Pharma - Tetraphase Pharmaceuticals - Theravance Biopharma - The Medicines Company - Valneva - Wockhardt Global Solutions Key Market drivers - Special regulatory designations - For a full, detailed list, view the full report Key Market challenges - Development of drug-resistant strains - For a full, detailed list, view the full report Key Market trends - Strategic alliances and M&A - For a full, detailed list, view the full report Key questions answered in this report - What will the market size be in 2019 and what will the growth rate be? - What are the Key Market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? Contents: PART 01: Executive summary

3 Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Antibacterial: overview Introduction Mechanism of action General principles for the use of antibiotics Clinical uses Epidemiology PART 06: Pipeline analysis Zerbaxa Surotomycin MK-3415A Amikacin Inhale CARBAVANCE Eravacycline Plazomicin Delafloxacin Solithromycin VivaGel Arikayce Cadazolid Ozenoxacin PART 07: Antimicrobial resistance Sources of spread of resistant organisms Initiatives to improve antibiotic innovation PART 08: Legislation relating to antibiotic use in the US PART 09: Market landscape Market overview Market size and forecast Five forces analysis PART 10: Market segmentation by chemical class Beta-lactam Macrolides Aminoglycosides Phenicols Quinolones Folate antagonists Tetracyclines Others PART 11: Market segmentation by drug origin Natural Semisynthetic Synthetic PART 12: Market segmentation by mechanism of action Bacteriostatic

4 Bactericidal PART 13: Market segmentation by spectrum of activity Broad spectrum antibiotics Narrow spectrum antibiotics PART 14: Geographical segmentation Global antibacterial drugs market by geographical segmentation Antibacterial drugs market in APAC Antibacterial drugs market in EMEA Antibacterial drugs market in Americas PART 15: Market drivers Special regulatory designations Increase in prevalence of infections Increase in awareness Increase in aging population PART 16: Impact of drivers PART 17: Market challenges Development of drug resistant strains Patent expiries and generic penetration Decreased investments in research activities PART 18: Impact of drivers and challenges PART 19: Market trends Strategic alliances and M&A Patient assistance programs Increased funding on antibiotic research PART 20: Vendor landscape Competitive scenario Market share analysis 2014 Other prominent vendors PART 21: Key vendor analysis Allergan GSK Merck Pfizer Sandoz Teva Pharmaceuticals PART 22: Appendix List of abbreviation PART 23: About the Author List of Exhibits Exhibit 01: Product offerings Exhibit 02: Mechanism of action of antibacterial drugs Exhibit 03: General principles involved in the use of antibiotics Exhibit 04: Estimated number of cases for nosocomial infections in US, 2011 Exhibit 05: Number of cases for Escherichia coli bacteremia in UK, Exhibit 06: Global antibacterial drugs market: Pipeline portfolio Exhibit 07: Causes of antimicrobial resistance Exhibit 08: Sources of spread of resistant organisms Exhibit 09: Estimated deaths per year caused by AMR in 2050 Exhibit 10: Initiatives improving antibiotic innovation Exhibit 11: Legislation relating to antibiotic use in US Exhibit 12: Global antibacterial drugs market ($ billions)

5 Exhibit 13: Five forces analysis Exhibit 14: Global antibacterial drugs market segmentation by chemical class Exhibit 15: Cephalosporin segmentation by generation of drugs Exhibit 16: Global antibacterial drugs market revenue segmentation by chemical class Exhibit 17: Global antibacterial drugs market segmentation by drug origin Exhibit 18: Global antibacterial drugs market segment by geography 2014 Exhibit 19: Antibacterial drugs market revenue by geography ($ billions) Exhibit 20: Antibacterial drugs market in APAC ($ billions) Exhibit 21: Antibacterial drugs market in EMEA ($ billions) Exhibit 22: Antibacterial drugs market in Americas ($ billions) Exhibit 23: Percentage share of antibacterial drugs market in Americas Exhibit 24: Impact of drivers Exhibit 25: Antibiotic-resistant strains according to the period of development of resistance Exhibit 26: Antibacterial drug approvals by FDA and EMA Exhibit 27: Impact of drivers and challenges Exhibit 28: Allergan: YoY growth and revenue generated from net product sales of anti-infective ($ millions) Exhibit 29: Allergan: Key takeaways Exhibit 30: GlaxoSmithKline: YoY growth and revenue generated from sales of Augmentin ($ millions) Exhibit 31: GlaxoSmithKline: Revenue generated from sales of Augmentin by region ($ millions) Exhibit 32: GlaxoSmithKline: YoY growth and revenue generated from sales of other antibacterials ($ millions) Exhibit 33: GlaxoSmithKline: Key takeaways Exhibit 34: Merck: YoY growth and revenue generated from sales of Primaxin ($ millions) Exhibit 35: Merck: YoY growth and revenue generated from sales of Invanz ($ millions) Exhibit 36: Merck: Key takeaways Exhibit 37: Pfizer: YoY growth and revenue generated from sales of Zyvox ($ millions) Exhibit 38: Pfizer: YoY growth and revenue generated from sales of Zithromax/Zmax ($ millions) Exhibit 39: Pfizer: YoY growth and revenue generated from sales of Unasyn ($ millions) Exhibit 40: Pfizer: YoY growth and revenue generated from sales of Zosyn/Tazocin ($ millions) Exhibit 41: Pfizer: YoY growth and revenue generated from sales of Sulperazon ($ millions) Exhibit 42: Pfizer: YoY growth and revenue generated from sales of Tygacil ($ millions) Exhibit 43: Pfizer: Key takeaways Exhibit 44: Sandoz: Key takeaways Exhibit 45: Teva Pharmaceuticals: Key takeaways Exhibit 46: Allergan: Business segmentation by product revenue 2014 Exhibit 47: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 48: Allergan: Geographical segmentation by revenue 2014 Exhibit 49: GSK: Business segmentation by revenue 2014 Exhibit 50: GSK: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 51: GSK: Geographical segmentation by revenue 2014 Exhibit 52: Merck: Business segmentation by revenue 2014 Exhibit 53: Merck: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 54: Merck: Geographical segmentation by revenue 2014 Exhibit 55: Pfizer: Business segmentation by revenue 2014 Exhibit 56: Pfizer business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 57: Pfizer: Geographical segmentation by revenue 2014 Exhibit 58: Sandoz: Business segmentation by revenue 2014 Exhibit 59: Teva Pharmaceuticals: Business segmentation by revenue 2014 Exhibit 60: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014 Exhibit 61: Teva Pharmaceuticals: Geographical segmentation by revenue 2014 Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre,

6 Taylors Lane, Dublin 8, Ireland.

7 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Global Antibacterial Drugs Market Web Address: Office Code: Product Formats Please select the product formats and quantity you require: SC Electronic (PDF) - Single User: Electronic (PDF) Users: Electronic (PDF) - Site License: Electronic (PDF) - Enterprisewide: Quantity USD 3000 USD 3500 USD 4500 USD * The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change. Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

8 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World